L-arginin in the complex treatment of the patients with arterial hypertension and diabetes mellitus in perimenopause

Authors

  • Kateryna Voloshynska Higher State Educational Institution of Ukraine «Bukovinian State Medical University» Teatralna sq., 2, Chernivtsi, Ukraine, 58002 State Institution "Territorial Medical Association of the Ministry of Internal Affairs of Ukraine in Kyiv" Platona Maiborody str., 19, Kyiv, Ukraine, 04050, Ukraine
  • Sergey Kovalchuk State Institution "Territorial Medical Association of the Ministry of Internal Affairs of Ukraine in Kyiv" Platona Maiborody str., 19, Kyiv, Ukraine, 04050, Ukraine
  • Maria Kovalchuk State Institution "Territorial Medical Association of the Ministry of Internal Affairs of Ukraine in Kyiv" Platona Maiborody str., 19, Kyiv, Ukraine, 04050, Ukraine
  • Olga Peresunko Municipal Medical Institution «Chernivtsi Regional Clinical Cardiology Dispensary» Heroiv Maidanu str., 230, Chernivtsi, Ukraine, 58013, Ukraine

DOI:

https://doi.org/10.15587/2519-4798.2020.193270

Keywords:

arterial hypertension, diabetes mellitus, endothelial dysfunction, myocardium, perimenopause, nitrogen oxide donator, L-arginin

Abstract

The aim of research was comparing the influence of basic therapy (lisinopril or amlodipine) as a monotherapy and its combination with nitrogen oxide donator – L-arginin in the patients with arterial hypertension in perimenopause with comorbid diabetes mellitus and without it.

Material and methods of our investigation: we examined 104 patients using biochemical (endothelin’s level determination) and instrumental (Doppler echocardiography) diagnostic methods.

Result. Results have shown that on the background of treatment, myocardial function improves and diastolic dysfunction is regressing in all patient’s groups. The most pronounced changes we can see in the subgroup of the patients, who additionally used L-arginine. The endothelin’s-1 level changes are also the most pronounced in patients, who used L-arginine. The feasibility of L-arginine adding is justified as it has positive influence on the endothelial dysfunction, which manifested itself in a decreased endothelin’s-1 level.

Conclusions. We have shown that on the background of treatment the myocardial contractility become better. The most pronounced changes we can see in the subgroup of the patients, who used L-arginine (diastolic dysfunction regressed from the second to the first type in 21 patients (47.7 %), which prove a positive influence on the left ventricular filling pressures)

Author Biographies

Kateryna Voloshynska, Higher State Educational Institution of Ukraine «Bukovinian State Medical University» Teatralna sq., 2, Chernivtsi, Ukraine, 58002 State Institution "Territorial Medical Association of the Ministry of Internal Affairs of Ukraine in Kyiv" Platona Maiborody str., 19, Kyiv, Ukraine, 04050

Department of Propedeutics of Internal Diseases

Cardiologist

Sergey Kovalchuk, State Institution "Territorial Medical Association of the Ministry of Internal Affairs of Ukraine in Kyiv" Platona Maiborody str., 19, Kyiv, Ukraine, 04050

Head of Department

Cardiology Department

Maria Kovalchuk, State Institution "Territorial Medical Association of the Ministry of Internal Affairs of Ukraine in Kyiv" Platona Maiborody str., 19, Kyiv, Ukraine, 04050

Doctor of Ultrasound Diagnostics

Olga Peresunko, Municipal Medical Institution «Chernivtsi Regional Clinical Cardiology Dispensary» Heroiv Maidanu str., 230, Chernivtsi, Ukraine, 58013

Doctor of Functional Diagnostics

References

  1. Sirenko, Yu M. (2012). Tsilovyi riven arterialnoho tysku u khvorykh na tsukrovyi diabet 2-ho typu: otsinka naukovykh dokaziv. Ukrainskyi kardiolohichnyi zhurnal, 6, 27–32.
  2. Wang, D., Wang, C., Wu, X., Zheng, W., Sandberg, K., Ji, H. et. al. (2014). Endothelial Dysfunction and Enhanced Contractility in Microvessels From Ovariectomized Rats: roles of oxidative stress and perivascular adipose. Hypertension, 63 (5), 1063–1069. doi: http://doi.org/10.1161/hypertensionaha.113.02284
  3. Avendaño, M. S., Lucas, E., Jurado-Pueyo, M., Martínez-Revelles, S., Vila-Bedmar, R., Mayor, F. et. al. (2014). Increased Nitric Oxide Bioavailability in Adult GRK2 Hemizygous Mice Protects Against Angiotensin II–Induced Hypertension. Hypertension, 63 (2), 369–375. doi: http://doi.org/10.1161/hypertensionaha.113.01991
  4. Carter, J. R., Fu, Q., Minson, C. T., Joyner, M. J. (2013). Ovarian Cycle and Sympathoexcitation in Premenopausal Women. Hypertension, 61 (2), 395–399. doi: http://doi.org/10.1161/hypertensionaha.112.202598
  5. Voloshynska, K. O., Ilashchuk, T. O. (2017). Clinical and pathogenetic peculiarities of type 2 diabetes in menopausal female patients. BDMU. Chernivci, 133.
  6. Bazylevych, A. Ya. (2014). Ohliad novyn Konhresu Yevropeiskoho tovarystva kardiolohiv. Liky Ukrainy, 7-8, 34–41.
  7. Böhm, M., Reil, J.-C., Deedwania, P., Kim, J. B., Borer, J. S. (2015). Resting Heart Rate: Risk Indicator and Emerging Risk Factor in Cardiovascular Disease. The American Journal of Medicine, 128 (3), 219–228. doi: http://doi.org/10.1016/j.amjmed.2014.09.016
  8. Spescha, R. D., Glanzmann, M., Simic, B., Witassek, F., Keller, S., Akhmedov, A. et. al. (2014). Adaptor Protein p66Shc Mediates Hypertension-Associated, Cyclic Stretch–Dependent, Endothelial Damage. Hypertension, 64 (2), 347–353. doi: http://doi.org/10.1161/hypertensionaha.113.02129
  9. ESH/ESC Guidelines for the management of arterial hypertension. (2013). European Heart Journal, 34 (28), 2159–2219. doi: http://doi.org/10.1093/eurheartj/eht151
  10. Caetano, J., Delgado Alves, J. (2015). Heart rate and cardiovascular protection. European Journal of Internal Medicine, 26 (4), 217–222. doi: http://doi.org/10.1016/j.ejim.2015.02.009
  11. Nascimento, M. A., Higa, E. M. S., de Mello, M. T., Tufik, S., Oyama, L. M., Santos, R. V. et. al. (2014). Effects of short-term l-arginine supplementation on lipid profile and inflammatory proteins after acute resistance exercise in overweight men. e-SPEN Journal, 9 (3), e141–e145. doi: http://doi.org/10.1016/j.clnme.2014.02.002

Published

2019-01-30

How to Cite

Voloshynska, K., Kovalchuk, S., Kovalchuk, M., & Peresunko, O. (2019). L-arginin in the complex treatment of the patients with arterial hypertension and diabetes mellitus in perimenopause. ScienceRise: Medical Science, (1 (34), 23–28. https://doi.org/10.15587/2519-4798.2020.193270

Issue

Section

Medical Science